Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Brittany VonBank"'
Autor:
Nicholas B. Lehnertz, Xiong Wang, Jacob Garfin, Joanne Taylor, Jennifer Zipprich, Brittany VonBank, Karen Martin, Dana Eikmeier, Carlota Medus, Brooke Wiedinmyer, Carmen Bernu, Matthew Plumb, Kelly Pung, Margaret A. Honein, Rosalind Carter, Duncan MacCannell, Kirk E. Smith, Kathryn Como-Sabetti, Kris Ehresmann, Richard Danila, Ruth Lynfield
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 8, Pp 2052-2063 (2021)
Coronavirus disease has disproportionately affected persons in congregate settings and high-density workplaces. To determine more about the transmission patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in these settings, we pe
Externí odkaz:
https://doaj.org/article/fe50ecc9ba01417dac2de4f1bdd088c2
Autor:
Jennifer Zipprich, Richard Danila, Brittany VonBank, Margaret A. Honein, Jacob Garfin, Dana Eikmeier, Duncan MacCannell, Carlota Medus, Kirk E. Smith, Joanne Taylor, Nicholas B. Lehnertz, Matthew Plumb, Karen Martin, Kris Ehresmann, Ruth Lynfield, Kathryn Como-Sabetti, Kelly Pung, Rosalind J Carter, Carmen Bernu, Xiong Wang, Brooke Wiedinmyer
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 27, Iss 8, Pp 2052-2063 (2021)
Emerging Infectious Diseases, Vol 27, Iss 8, Pp 2052-2063 (2021)
Coronavirus disease has disproportionately affected persons in congregate settings and high-density workplaces. To determine more about the transmission patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in these settings, we pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e602c4ce6215230aac1b837c10d74779
https://doi.org/10.3201/eid2708.204838
https://doi.org/10.3201/eid2708.204838
Autor:
Melissa Anacker, Medora Witwer, Mariana Castanheira, Brittany VonBank, James R. Johnson, Stephen B. Porter, Paul Thuras, Paula Snippes Vagnone, Brian D. Johnston
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases.
The emergence of carbapenem-resistant (CR) Escherichia coli obliges an assessment of such strains’ molecular epidemiology. Accordingly, we characterized in detail a globally distributed collection of CR E. coli isolates, then explored for associati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0b28858082f6a7ac4c1aa02a1ea3360
https://doi.org/10.1007/s10096-021-04310-6
https://doi.org/10.1007/s10096-021-04310-6
Autor:
Brenda L Tesini, Brittany VonBank, Helen Johnston, Kaytlynn Marceaux, Sarah Shrum, Joelle Nadle, Sabrina R Williams, Rajal K. Mody, Devra Barter, Erin C Phipps, Snigdha Vallabhaneni, Sarah Petnic, Alexia Y Zhang, Tom Chiller, Rebecca Pierce, Lindsay Bonner, Brendan R Jackson, Lee H. Harrison, Monica M. Farley, Rosemary Hollick, William Schaffner
Publikováno v:
Clinical Infectious Diseases. 71:1732-1737
Background Injection drug use (IDU) is a known, but infrequent risk factor on candidemia; however, the opioid epidemic and increases in IDU may be changing the epidemiology of candidemia. Methods Active population-based surveillance for candidemia wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266f5aa23f6221e3e989ad61fea22375
https://doi.org/10.1093/cid/ciz1061
https://doi.org/10.1093/cid/ciz1061
Autor:
Brian D, Johnston, Paul, Thuras, Stephen B, Porter, Melissa, Anacker, Brittany, VonBank, Paula Snippes, Vagnone, Medora, Witwer, Mariana, Castanheira, James R, Johnson
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology.
The emergence of carbapenem-resistant (CR) Escherichia coli obliges an assessment of such strains' molecular epidemiology. Accordingly, we characterized in detail a globally distributed collection of CR E. coli isolates, then explored for association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::444461d27f4035db1aaa538ed00a6da6
https://pubmed.ncbi.nlm.nih.gov/34278542
https://pubmed.ncbi.nlm.nih.gov/34278542
Autor:
Kris Ehresmann, Joanne Taylor, Carlota Medus, Karen Martin, Margaret A. Honein, Duncan MacCannell, Brittany VonBank, Jennifer Zipprich, Matthew Plumb, Kathryn Como-Sabetti, Kirk E. Smith, Rosalind J Carter, Richard Danila, Jacob Garfin, Carmen Bernu, Dana Eikmeier, Nicholas B. Lehnertz, Kelly Pung, Ruth Lynfield, Xiong Wang, Brooke Wiedinmyer
Congregate settings and high-density workplaces have endured a disproportionate impact from COVID-19. In order to provide further understanding of the transmission patterns of SARS-CoV-2 in these settings, whole genome sequencing (WGS) was performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7919b4914540f92d2d242bc09ad1aea2
https://doi.org/10.1101/2020.12.30.20248277
https://doi.org/10.1101/2020.12.30.20248277
Autor:
James R. Johnson, Medora Witwer, Mariana Castanheira, Brittany VonBank, Stephen Porter, Melissa Anacker, Paul Thuras, Paula Snippes Vagnone, Brian D. Johnston
Publikováno v:
The Journal of antimicrobial chemotherapy. 76(8)
BackgroundEmerging carbapenem resistance in Escherichia coli, including sequence type 131 (ST131), threatens therapeutic efficacy. Plazomicin (PLZ), a semisynthetic aminoglycoside approved by the FDA in 2018, overcomes the most common aminoglycoside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84b812f9ecafd15835ee0cf3f88f4d8
https://pubmed.ncbi.nlm.nih.gov/34097032
https://pubmed.ncbi.nlm.nih.gov/34097032
Autor:
Melissa Anacker, James R. Johnson, Brittany VonBank, Medora Witwer, Mariana Castanheira, Brian D. Johnston, Stephen Porter, Paul Thuras, Paula Snippes Vagnone
Publikováno v:
Antimicrob Agents Chemother
Imipenem-relebactam (I-R) is a recently developed carbapenem–beta-lactamase inhibitor combination agent that can overcome carbapenem resistance, which has now emerged in Escherichia coli, including sequence type 131 (ST131) and its fluoroquinolone-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0bc8796e699b3f3629dbdd2c44d4ea4
https://doi.org/10.1128/aac.02408-19
https://doi.org/10.1128/aac.02408-19
Autor:
Erin C Phipps, Tom Chiller, Sabrina R Williams, Sarah Shrum, Rajal K. Mody, Brendan R Jackson, Brittany VonBank, Snigdha Vallabhaneni, Devra Barter, Sarah Petnic, Rebecca Pierce, Alexia Y Zhang, Lee H. Harrison, Sherry Hillis, William Schaffner, Ghinwa Dumyati, Monica M. Farley
Publikováno v:
Open Forum Infectious Diseases
Background Known risk factors for candidemia include diabetes, malignancy, antibiotics, total parenteral nutrition (TPN), prolonged hospitalization, abdominal surgery, and central venous catheters. Injection drug use (IDU) is not a common risk factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590554245d38ca6f013760256d4cc0e8
https://doi.org/10.1093/ofid/ofy209.128
https://doi.org/10.1093/ofid/ofy209.128
Autor:
Monica M. Farley, Helen Johnston, William Schaffner, Sarah Shrum, Ghinwa Dumyati, Sabrina R Williams, Lee H. Harrison, Yi Mu, Sharon Tsay, Snigdha Vallabhaneni, Shelley S. Magill, Alexia Zhang, Erin Epson, Brittany VonBank
Publikováno v:
Open Forum Infectious Diseases
Background Candidemia is a common healthcare-associated bloodstream infection associated with high morbidity and mortality. No current estimates exist for understanding its burden in the United States. Methods In 2017, CDC’s Emerging Infections Pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0688b5381c7da92c2997da64e1530fe
http://europepmc.org/articles/PMC6255127
http://europepmc.org/articles/PMC6255127